![](/img/cover-not-exists.png)
O020 Asthma exacerbations and lung function decline in children during a 52-week controlled trial of omalizumab
Chipps, B., Szefler, S., Rosen, K., Haselkorn, T., Trzaskoma, B., Ortiz, B., Lanier, B., Busse, W.Volume:
117
Language:
english
Journal:
Annals of Allergy, Asthma & Immunology
DOI:
10.1016/j.anai.2016.09.380
Date:
November, 2016
File:
PDF, 980 KB
english, 2016